Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of vildagliptin and glimepiride on glycemic variability and cardiovascular parameters in type 2 diabetes with basal insulin failure
2013-002955-13Phase 4Active
- Sponsor
- American Federation for Aging Research
- Start
- Sep 2013
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vildagliptin and glimepiride in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by American Federation for Aging Research. Primary endpoint: Time in euglycemia. Started Sep 2013; status: active.
02
Drugs
vildagliptinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-002955-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002955-13.